| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | IG | 8.69e-04 | 421 | 50 | 6 | SM00409 | |
| Domain | Ig_sub | 8.69e-04 | 421 | 50 | 6 | IPR003599 | |
| Domain | fn3 | 9.21e-04 | 162 | 50 | 4 | PF00041 | |
| Domain | FN3 | 1.50e-03 | 185 | 50 | 4 | SM00060 | |
| Domain | Ig_I-set | 1.66e-03 | 190 | 50 | 4 | IPR013098 | |
| Domain | I-set | 1.66e-03 | 190 | 50 | 4 | PF07679 | |
| Domain | IG_LIKE | 1.91e-03 | 491 | 50 | 6 | PS50835 | |
| Domain | FN3 | 1.96e-03 | 199 | 50 | 4 | PS50853 | |
| Domain | Ig-like_dom | 2.16e-03 | 503 | 50 | 6 | IPR007110 | |
| Domain | FN3_dom | 2.35e-03 | 209 | 50 | 4 | IPR003961 | |
| Domain | Ig-like_fold | 2.60e-03 | 706 | 50 | 7 | IPR013783 | |
| Domain | IGc2 | 3.58e-03 | 235 | 50 | 4 | SM00408 | |
| Domain | Ig_sub2 | 3.58e-03 | 235 | 50 | 4 | IPR003598 | |
| Domain | - | 3.95e-03 | 35 | 50 | 2 | 3.20.20.80 | |
| Domain | Glyco_hydro_catalytic_dom | 4.64e-03 | 38 | 50 | 2 | IPR013781 | |
| Domain | - | 8.24e-03 | 663 | 50 | 6 | 2.60.40.10 | |
| Domain | Glycoside_hydrolase_SF | 8.87e-03 | 53 | 50 | 2 | IPR017853 | |
| Domain | RhoGAP | 1.20e-02 | 62 | 50 | 2 | SM00324 | |
| Domain | RhoGAP | 1.24e-02 | 63 | 50 | 2 | PF00620 | |
| Domain | RHOGAP | 1.27e-02 | 64 | 50 | 2 | PS50238 | |
| Domain | RhoGAP_dom | 1.27e-02 | 64 | 50 | 2 | IPR000198 | |
| Domain | - | 1.27e-02 | 64 | 50 | 2 | 1.10.555.10 | |
| Pubmed | 7.09e-06 | 3 | 54 | 2 | 31098770 | ||
| Pubmed | 1.42e-05 | 4 | 54 | 2 | 1838307 | ||
| Pubmed | 2.36e-05 | 5 | 54 | 2 | 27539848 | ||
| Pubmed | The role of Robo3 in the development of cortical interneurons. | 3.54e-05 | 6 | 54 | 2 | 19366869 | |
| Pubmed | 4.94e-05 | 7 | 54 | 2 | 20962249 | ||
| Pubmed | Efficient generation of B lymphocytes by recognition of self-antigens. | 4.94e-05 | 7 | 54 | 2 | 21604259 | |
| Pubmed | Mig-6 controls EGFR trafficking and suppresses gliomagenesis. | 5.12e-05 | 46 | 54 | 3 | 20351267 | |
| Pubmed | 1.06e-04 | 10 | 54 | 2 | 22284677 | ||
| Pubmed | 1.29e-04 | 11 | 54 | 2 | 34111600 | ||
| Pubmed | A role for Nr-CAM in the patterning of binocular visual pathways. | 1.55e-04 | 12 | 54 | 2 | 16701205 | |
| Pubmed | A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. | 1.83e-04 | 13 | 54 | 2 | 21079607 | |
| Pubmed | Pioneering axons regulate neuronal polarization in the developing cerebral cortex. | 1.83e-04 | 13 | 54 | 2 | 24559674 | |
| Pubmed | Role of Rb during Neurogenesis and Axonal Guidance in the Developing Olfactory System. | 2.45e-04 | 15 | 54 | 2 | 27667971 | |
| Pubmed | Mash1 is required for neuroendocrine cell development in the glandular stomach. | 2.80e-04 | 16 | 54 | 2 | 18173746 | |
| Pubmed | PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. | 3.17e-04 | 17 | 54 | 2 | 11869689 | |
| Pubmed | Dlx-dependent and -independent regulation of olfactory bulb interneuron differentiation. | 3.17e-04 | 17 | 54 | 2 | 17376983 | |
| Pubmed | Wnt/β-catenin promotes gastric fundus specification in mice and humans. | 3.56e-04 | 18 | 54 | 2 | 28052057 | |
| Pubmed | 3.90e-04 | 91 | 54 | 3 | 22610502 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 4.40e-04 | 1489 | 54 | 9 | 28611215 | |
| Pubmed | FOXG1 Orchestrates Neocortical Organization and Cortico-Cortical Connections. | 4.42e-04 | 20 | 54 | 2 | 30392794 | |
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 4.42e-04 | 20 | 54 | 2 | 29961574 | |
| Pubmed | 5.02e-04 | 650 | 54 | 6 | 38777146 | ||
| Pubmed | ETS-dependent regulation of a distal Gata4 cardiac enhancer. | 6.39e-04 | 24 | 54 | 2 | 22056786 | |
| Pubmed | Robo1 modulates proliferation and neurogenesis in the developing neocortex. | 8.10e-04 | 27 | 54 | 2 | 24741061 | |
| Pubmed | 8.51e-04 | 272 | 54 | 4 | 31010829 | ||
| Pubmed | 1.01e-03 | 126 | 54 | 3 | 16284245 | ||
| Pubmed | 1.14e-03 | 32 | 54 | 2 | 23049088 | ||
| Pubmed | 1.21e-03 | 33 | 54 | 2 | 9244437 | ||
| Pubmed | Multiple roles of epithelial heparan sulfate in stomach morphogenesis. | 1.36e-03 | 35 | 54 | 2 | 29700203 | |
| Pubmed | 1.44e-03 | 36 | 54 | 2 | 37497580 | ||
| Pubmed | 1.54e-03 | 1429 | 54 | 8 | 35140242 | ||
| GeneFamily | Fibronectin type III domain containing | 2.79e-04 | 160 | 36 | 4 | 555 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.90e-08 | 146 | 52 | 6 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 3.66e-08 | 163 | 52 | 6 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 8.26e-07 | 148 | 52 | 5 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.18e-06 | 159 | 52 | 5 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-05 | 128 | 52 | 4 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | COVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type | 1.57e-05 | 129 | 52 | 4 | 57b705106aec7bbfc587de1ccd4f2335fc44dd6f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 139 | 52 | 4 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 2.10e-05 | 139 | 52 | 4 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.48e-05 | 145 | 52 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.69e-05 | 148 | 52 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.84e-05 | 150 | 52 | 4 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.83e-05 | 162 | 52 | 4 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.56e-05 | 186 | 52 | 4 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 188 | 52 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.98e-05 | 189 | 52 | 4 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-05 | 189 | 52 | 4 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.98e-05 | 189 | 52 | 4 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 191 | 52 | 4 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.56e-05 | 193 | 52 | 4 | cd45118ced91b10baed3b1068d4673ec99824b86 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-05 | 198 | 52 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-05 | 198 | 52 | 4 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.35e-05 | 198 | 52 | 4 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.51e-05 | 199 | 52 | 4 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | f599e4b051ac3dad11ad437e98dc8ea6754cca53 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.68e-05 | 200 | 52 | 4 | dcdaec3ca3a3024dc1b8788c417003f84c2bffdc | |
| Disease | caudate nucleus measurement, functional brain measurement, response to reward | 6.23e-05 | 47 | 48 | 3 | EFO_0007849, EFO_0008387, EFO_0008396 | |
| Disease | atrial fibrillation | 3.36e-04 | 371 | 48 | 5 | EFO_0000275 | |
| Disease | comparative body size at age 10, self-reported | 5.91e-04 | 420 | 48 | 5 | EFO_0009819 | |
| Disease | response to vaccine, cytokine measurement | 1.28e-03 | 131 | 48 | 3 | EFO_0004645, EFO_0004873 | |
| Disease | Paroxysmal atrial fibrillation | 2.11e-03 | 156 | 48 | 3 | C0235480 | |
| Disease | Persistent atrial fibrillation | 2.11e-03 | 156 | 48 | 3 | C2585653 | |
| Disease | familial atrial fibrillation | 2.11e-03 | 156 | 48 | 3 | C3468561 | |
| Disease | Atrial Fibrillation | 2.26e-03 | 160 | 48 | 3 | C0004238 | |
| Disease | dimethylglycine measurement | 2.56e-03 | 46 | 48 | 2 | EFO_0010476 | |
| Disease | Myopia | 3.53e-03 | 385 | 48 | 4 | HP_0000545 | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 4.18e-03 | 59 | 48 | 2 | EFO_0001663, MONDO_0005148 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SWQSESLPVSLSASQ | 246 | Q9BXK5 | |
| WVNTLSSSSLLTNAD | 246 | Q92905 | |
| SSTSNQLWLEFNSDT | 1321 | Q7Z407 | |
| LSTANLPNSSSTLGW | 86 | Q9BXY5 | |
| SNKSWDLLIPQASSN | 146 | Q96PJ5 | |
| TASLLTFWNLPNSAQ | 21 | Q14002 | |
| NTVLNKSSNWGTSPL | 246 | Q9BV10 | |
| TLSASSPSWLGAAQN | 61 | O94779 | |
| SSWPLSQNGTNTEAT | 11 | Q9GZQ6 | |
| QWLNPQSPTTTSSNS | 686 | A1A4S6 | |
| SSDPATESTQNNQWT | 701 | Q86TB9 | |
| NLDELSSSSSWLLNQ | 521 | A0AUZ9 | |
| VNIARPSSQQSSWTS | 86 | Q7Z353 | |
| PSSQQSSWTSANNDV | 91 | Q7Z353 | |
| ISSNNRQTLPCVSWS | 1246 | Q71F56 | |
| QSSPASSLNSWFSAA | 406 | Q6P4R8 | |
| SISTSVSYQAPNNTW | 371 | P61550 | |
| LTSASSWISNLPNNS | 56 | Q5W064 | |
| NVTLSTQPISSLDWS | 316 | Q96MX6 | |
| GSWAQSALTQPASVS | 16 | P01705 | |
| PASSDFSDLNTQTNW | 181 | Q5SYE7 | |
| FESSDSLLQSWNSQS | 286 | P15036 | |
| STAAQSQLTAALTSW | 211 | A0A1B0GTW7 | |
| SRLAWTLTANQPSSQ | 201 | Q96CW5 | |
| NVTSTWNLASPLLSV | 591 | P05165 | |
| NPNNSWNSSSALSLL | 231 | Q8WWQ2 | |
| SSSDAQQSLQSFWPR | 11 | Q13952 | |
| SWQLVQTQCLPSSSN | 3151 | P78509 | |
| LLVSVTGNSSNSWPS | 216 | Q14953 | |
| QSPQTSSKQDSWNSL | 416 | P43694 | |
| LLWATAGTSTQTQSS | 11 | P27352 | |
| LFTLLSTQDQNSSSW | 541 | O14981 | |
| STQDQNSSSWLIPIL | 546 | O14981 | |
| STTSQLSWRAGPDNN | 611 | Q9UQ52 | |
| NPGLTHTSNSSQWNT | 121 | Q3C1V0 | |
| SWNNITDSLDPATLS | 156 | Q8WWB7 | |
| ASRQVSPLLASQSWS | 741 | Q9Y4F3 | |
| SQSWSSRSMSPNLLN | 751 | Q9Y4F3 | |
| NCTWNSSSEPQPTNL | 71 | P31785 | |
| AQSVLQSLPSSQWSV | 2426 | Q9P225 | |
| WAQSNTTAQCLPSLA | 571 | Q13183 | |
| SLPQFWLSSAVNSSS | 391 | Q12889 | |
| QSSKPSSAQQASELW | 16 | Q9BZF2 | |
| GSWAQSALTQPASVS | 16 | P01704 | |
| NDSSVALSSWGQQPS | 1551 | Q8WUY3 | |
| SQNSSLWAQLSSTQT | 216 | Q7L2K0 | |
| SALPSWAFANLSSLQ | 81 | Q8N967 | |
| GQWRNSTPSSSSSLQ | 96 | Q9P0U3 | |
| SWSISLPSNNCTKNV | 131 | Q6ZNX1 | |
| LVWNTQSSSLQATPS | 396 | Q9BZV3 | |
| ASSLLSQFRSPSWQT | 106 | Q9ULL5 | |
| TLQPWNSDSTLNSRQ | 251 | Q9H0H5 | |
| SWNAKLQLQSETSSS | 561 | Q13023 | |
| STDLFSSIQSPSNWN | 126 | Q6ZN11 | |
| DSWPATSLPVNNSNS | 926 | Q9HCK4 | |
| SRNSSSAWPNLTSQE | 226 | P10073 | |
| SPNILNNSMSSWSQL | 1591 | Q96QT4 | |
| LSPAQTSQVTSLSSW | 101 | Q86TJ5 |